| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal ID12063: Testosterone cream for treating hypoactive sexual desire dysfunction after menopause |
|
Medicine details |
|
| Medicine name | testosterone (AndroFeme®) |
| Formulation | 10 mg/ml cream |
| Reference number | 921 |
| Indication | Treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women on optimised hormone replacement therapy (HRT) |
| Company | Andro Pharmaceuticals Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Scrutiny Panel meeting date | 18/12/2025 |
| Further information This medicine was considered by the AWMSG Scrutiny Panel in December 2025 as suitable for full assessment. However, this medicine has subsequently been selected for assessment by NICE. Therefore, AWMSG will not be progressing with an assessment as the NICE recommendation will also apply to NHS Wales. |
|